Sponsor or institution
Clinical trials and research at Lamassu Pharma INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
One Health approach to a new treatment for acute pancreatitis in people and dogs
A new drug, RABI-767, is being developed to treat acute pancreatitis in both humans and dogs, aiming to prevent organ failure.
-
A New Treatment for Severe Pancreatitis
This work explores a new medicine, RABI-767, to help manage severe acute pancreatitis in both people and animals.
-
Developing a new treatment for acute pancreatitis in dogs and humans
This study is exploring a new treatment for acute pancreatitis, a serious condition that currently has no good options, by testing a promising compound called RABI-767 in dogs to see how well it works and is tolerated, which will help us develop better therapies for both dogs and people in the future.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.